A synthetic peptide for use as a blocking control in assays to test for specificity of EDA antibody, Alternative Names: Ectodysplasin A control peptide, Ectodysplasin A antibody Blocking Peptide, Anti-Ectodysplasin A Blocking Peptide, ED1 Blocking Peptide, ED1-A1 Blocking Peptide, ED1-A2 Blocking Peptide, EDA1 Blocking Peptide, EDA2 Blocking Peptide, HED Blocking Peptide, XHED Blocking Peptide, XLHED Blocking Peptide, EDA Blocking Peptide
EDA
Reaktivität: Human
Wirt: Synthetic
BP, BI
Sodium azide
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
Ectodysplasin A (EDA)
Hintergrund
EDA is a type II membrane protein that can be cleaved by furin to produce a secreted form. It belongs to the tumor necrosis factor family, acts as a homotrimer and may be involved in cell-cell signaling during the development of ectodermal organs. Defects in this gene are a cause of ectodermal dysplasia, anhidrotic, which is also known as X-linked hypohidrotic ectodermal dysplasia. Several transcript variants encoding many different isoforms have been found for this gene.